Switch theme
Sign up to access all valuation multiples
Suzhou Sepax Technologies Co Ltd is engaged in the Research, development and produce liquid chromatography materials for drug analysis, detection, separation and purification.
2009
n/a
Last FY Revenue $44.1M
Last FY EBITDA $17.0M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Suzhou Sepax Technologies achieved revenue of $44.1M and an EBITDA of $17.0M.
Suzhou Sepax Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Suzhou Sepax Technologies valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $44.1M | XXX | XXX | XXX |
| Gross Profit | XXX | $31.3M | XXX | XXX | XXX |
| Gross Margin | XXX | 71% | XXX | XXX | XXX |
| EBITDA | XXX | $17.0M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 39% | XXX | XXX | XXX |
| EBIT | XXX | $13.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | 31% | XXX | XXX | XXX |
| Net Profit | XXX | $11.9M | XXX | XXX | XXX |
| Net Margin | XXX | 27% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 31, 2025, Suzhou Sepax Technologies's stock price is CNY 19 (or $3).
Suzhou Sepax Technologies has current market cap of CNY 7.9B (or $1.1B), and EV of CNY 7.7B (or $1.1B).
See Suzhou Sepax Technologies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $1.1B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 31, 2025, Suzhou Sepax Technologies has market cap of $1.1B and EV of $1.1B.
Suzhou Sepax Technologies's trades at 24.3x EV/Revenue multiple, and 63.0x EV/EBITDA.
Equity research analysts estimate Suzhou Sepax Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Suzhou Sepax Technologies's P/E ratio is not available.
See valuation multiples for Suzhou Sepax Technologies and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 24.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 63.0x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 78.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 93.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 146.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSuzhou Sepax Technologies's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Suzhou Sepax Technologies's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Suzhou Sepax Technologies's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Suzhou Sepax Technologies and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | 21% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 39% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| AnteoTech | XXX | XXX | XXX | XXX | XXX | XXX |
| Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
| Biohit | XXX | XXX | XXX | XXX | XXX | XXX |
| Genomictree | XXX | XXX | XXX | XXX | XXX | XXX |
| Avacta Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Suzhou Sepax Technologies acquired XXX companies to date.
Last acquisition by Suzhou Sepax Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . Suzhou Sepax Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Suzhou Sepax Technologies founded? | Suzhou Sepax Technologies was founded in 2009. |
| Where is Suzhou Sepax Technologies headquartered? | Suzhou Sepax Technologies is headquartered in China. |
| Is Suzhou Sepax Technologies publicy listed? | Yes, Suzhou Sepax Technologies is a public company listed on SHG. |
| What is the stock symbol of Suzhou Sepax Technologies? | Suzhou Sepax Technologies trades under 688758 ticker. |
| When did Suzhou Sepax Technologies go public? | Suzhou Sepax Technologies went public in 2025. |
| Who are competitors of Suzhou Sepax Technologies? | Similar companies to Suzhou Sepax Technologies include e.g. AnteoTech, Proteomics International, Biohit, Genomictree. |
| What is the current market cap of Suzhou Sepax Technologies? | Suzhou Sepax Technologies's current market cap is $1.1B |
| Is Suzhou Sepax Technologies profitable? | Yes, Suzhou Sepax Technologies is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
